Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Syncope	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
NONE	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
a	O
___	O
year	O
old	O
woman	O
with	O
CAD	O
s/p	O
a	O
recent	O
CABG	O
x	O
2,	O
who	O
presented	O
from	O
dialysis	O
center	O
with	O
right	O
sided	O
chest	O
pain	O
at	O
rest	O
that	O
was	O
not	O
relieved	O
by	O
nitro.	O
She	O
did	O
not	O
get	O
HD.	O
She	O
states	O
that	O
it	O
is	O
intermittent,	O
lasts	O
for	O
___	O
seconds,	O
happens	O
approximately	O
several	O
times	O
per	O
day,	O
and	O
then	O
resolves.	O
She	O
notes	O
no	O
exertional	O
exacerbation	O
or	O
pleuisy	O
and	O
it	O
is	O
reproducible	O
with	O
palpation.	O
She	O
has	O
not	O
respiratory	O
symptoms,	O
cough,	O
vomiting,	O
diarrhea.	O
Initial	O
ED	O
vitals	O
were:	O
___	O
1022:	O
7	O
98.9	O
80	O
139/64	O
20	O
100%	O
0	O
She	O
was	O
placed	O
in	O
ED	O
observation	O
for	O
trending	O
enzymes	O
which	O
showed	O
0.07	O
>0.10	O
>0.12	O
with	O
normal	O
CK-MBs.	O
EKG	O
was	O
at	O
baseline.	O
Her	O
labs	O
were	O
otherwise	O
notable	O
for	O
a	O
Hgb	O
of	O
6.8	O
(down	O
from	O
8	O
on	O
admission).	O
There	O
was	O
no	O
evidence	O
of	O
bleeding	B-Lower_gastrointestinal_haemorrhage
and	O
the	O
ED	O
rectal	B-Lower_gastrointestinal_haemorrhage
exam	O
was	O
guaiac	O
negative.	O
She	O
had	O
HD	O
today	O
as	O
an	O
inpatient.	O
She	O
was	O
admitted	O
for	O
a	O
blood	O
transfusion.	O
Vitals	O
on	O
transfer	O
were:	O
VS	O
98.7	O
111/52	O
69	O
18	O
100%	O
___	O
WT	O
64.8	O
kg	O
Past	O
Medical	O
History:	O
#CAD,	O
s/p	O
CABG	O
___	O
(SVG	O
to	O
LAD	O
and	O
SVG	O
to	O
ramus),	O
last	O
cath	O
___	O
with	O
60%	O
ulcerated	O
left	O
main,	O
30%	O
___	O
and	O
30%	O
mid	O
LAD,	O
30%	O
mid	O
LCx,	O
60%	O
OM1,	O
30%	O
mid	O
RCA	O
(right	O
dominant)	O
#ESRD	O
on	O
HD	O
#Hypertension	O
#Hx	O
tobacco	O
use	O
#Gout	O
#OA	O
#Low	O
back	O
pain	O
#Anemia	O
#CHF	O
with	O
preserved	O
systolic	O
function	O
#Hx	O
ETOH	O
abuse,	O
quit	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Denies	O
any	O
history	O
of	O
cardiac	O
disease	O
or	O
renal	O
disease.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
Vitals:	O
T:97.9	O
BP:153/79	O
HR:80	O
RR:16	O
02	O
sat:98%RA	O
GENERAL:	O
WD	O
WN	O
female	O
comfortable	O
in	O
NAD	O
HEENT:	O
NCAT,	O
wig	O
on	O
head,	O
EOMI,	O
PERRL,	O
MMM,	O
supple	O
neck,	O
no	O
LAD,	O
no	O
JVD	O
CARDIAC:	O
RRR,	O
S1,	O
S2,	O
bruit	O
audible	O
throughout	O
precordium	O
LUNG:	O
CTAB,	O
no	O
w/r/r	O
without	O
use	O
of	O
accessory	O
muscles	O
ABDOMEN:	O
nondistended,	O
+BS,	O
nontender	O
in	O
all	O
quadrants,	O
no	O
rebound/guarding,	O
no	O
hepatosplenomegaly	O
EXTREMITIES:	O
moving	O
all	O
extremities	O
well,	O
no	O
cyanosis,	O
clubbing	O
or	O
edema,	O
fistula	O
in	O
LUE	O
with	O
palpable	O
thrill	O
and	O
audible	O
bruit	O
PULSES:	O
2+	O
DP	O
pulses	O
bilaterally	O
NEURO:	O
CN	O
II-XII	O
intact	O
SKIN:	O
warm	O
and	O
well	O
perfused,	O
no	O
excoriations	O
or	O
lesions,	O
no	O
rashes	O
DISCHARGE	O
PHYSICAL	O
EXAM	O
VS:	O
T	O
99.1	O
___	O
81-102	O
16	O
99%	O
___	O
GEN:	O
Pleasant	O
woman	O
in	O
NAD	O
NECK:	O
JVP	O
not	O
elevated	O
CV:	O
RRR.	O
normal	O
S1,S2.	O
No	O
murmurs,	O
rubs,	O
clicks,	O
or	O
gallops.	O
Audible	O
fistula	O
sounds	O
across	O
precordium.	O
LUNGS:	O
CTAB.	O
ABD:	O
Soft,	O
NT,	O
ND.	O
No	O
HSM.	O
EXT:	O
2+	O
DP	O
pulses,	O
no	O
edema	O
SKIN:	O
No	O
rashes/lesions,	O
ecchymoses.	O
NEURO:	O
A&Ox3.	B-Delirium
CN	O
___	O
intact	O
to	O
confrontation.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
--------------	O
___	O
05:20PM	O
BLOOD	O
WBC-6.4	O
RBC-4.23#	O
Hgb-10.5*#	O
Hct-34.9*#	O
MCV-82	O
MCH-24.9*	O
MCHC-30.2*	O
RDW-23.3*	O
Plt	O
___	O
___	O
05:20PM	O
BLOOD	O
Neuts-70	O
Bands-0	O
___	O
Monos-4	O
Eos-0	O
Baso-0	O
Atyps-2*	O
___	O
Myelos-0	O
___	O
05:20PM	O
BLOOD	O
Hypochr-2+	O
Anisocy-1+	O
Poiklo-2+	O
Macrocy-NORMAL	O
Microcy-2+	O
Polychr-1+	O
Ovalocy-1+	O
Target-1+	O
Schisto-1+	O
Acantho-1+	O
Ellipto-1+	O
___	O
05:20PM	O
BLOOD	O
Glucose-103*	O
UreaN-6	O
Creat-3.5*#	O
Na-134	O
K-4.7	O
Cl-92*	O
HCO3-30	O
AnGap-17	O
___	O
07:00AM	O
BLOOD	O
Calcium-10.1	O
Phos-4.2	O
Mg-2.3	O
PERTINENT	O
LABS	O
--------------	O
___	O
05:20PM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.32*	O
___	O
01:33AM	O
BLOOD	O
CK-MB-1	O
cTropnT-0.34*	O
___	O
07:00AM	O
BLOOD	O
CK-MB-1	O
cTropnT-0.34*	O
___	O
05:20PM	O
BLOOD	O
D-Dimer-4025*	O
___	O
07:00PM	O
BLOOD	O
D-Dimer-3035*	O
DISCHARGE	O
LABS	O
--------------	O
___	O
07:00AM	O
BLOOD	O
WBC-6.8	O
RBC-3.88*	O
Hgb-9.4*	O
Hct-32.2*	O
MCV-83	O
MCH-24.2*	O
MCHC-29.3*	O
RDW-23.3*	O
Plt	O
___	O
___	O
07:00AM	O
BLOOD	O
Glucose-80	O
UreaN-14	O
Creat-5.2*#	O
Na-136	O
K-4.3	O
Cl-92*	O
HCO3-30	O
AnGap-18	O
MICRO	O
-----	O
BLOOD	O
CULTURE	O
___:	O
pending	O
URINE	O
CULTURE	O
___:	O
pending	O
IMAGING	O
-------	O
___	O
CTA:	O
FINDINGS:	O
Although	O
this	O
study	O
is	O
not	O
designed	O
for	O
assessment	O
of	O
intra-abdominal	O
structures,	O
the	O
visualized	O
solid	O
organs	O
and	O
stomach	O
are	O
unremarkable.	O
CT	O
chest:	O
The	O
thyroid	O
is	O
unremarkable	O
and	O
there	O
is	O
no	O
supraclavicular	O
lymph	O
node	O
enlargement.	O
The	O
airways	O
are	O
patent	O
to	O
the	O
subsegmental	O
level.	O
There	O
is	O
no	O
mediastinal,	O
hilar	O
or	O
axillary	O
lymph	O
node	O
enlargement	O
by	O
CT	O
size	O
criteria.	O
There	O
is	O
mild	O
cardiomegaly.	O
The	O
patient	O
is	O
status	O
post	O
median	O
sternotomy	O
with	O
post	O
surgical	O
changes	O
in	O
the	O
mediastinum.	O
The	O
native	O
vessels	O
demonstrate	O
severe	O
atherosclerotic	O
disease.	O
The	O
pulmonary	O
artery	O
is	O
dilated	O
to	O
4	O
cm	O
consistent	O
with	O
pulmonary	O
artery	O
hypertension.	O
No	O
hiatal	O
hernia	O
or	O
other	O
esophageal	O
abnormality	O
is	O
present.	O
There	O
is	O
a	O
5	O
mm	O
nodule	O
in	O
the	O
left	O
lower	O
lobe	O
(2:64).	O
A	O
linear	O
opacity	O
at	O
the	O
left	O
lung	O
base	O
most	O
likely	O
represents	O
scarring.	O
Emphysematous	O
changes	O
are	O
noted.	O
No	O
pleural	O
effusion	O
or	O
pneumothorax	O
is	O
present.	O
CTA	O
chest:	O
The	O
aorta	O
and	O
major	O
thoracic	O
vessels	O
are	O
well	O
opacified.	O
The	O
aorta	O
demonstrates	O
normal	O
caliber	O
throughout	O
the	O
thorax	O
without	O
intramural	O
hematoma	O
or	O
dissection.	O
The	O
pulmonary	O
arteries	O
are	O
opacified	O
to	O
the	O
subsegmental	O
level.	O
There	O
is	O
no	O
filling	O
defect	O
in	O
the	O
main,	O
right,	O
left,	O
lobar	O
or	O
subsegmental	O
pulmonary	O
arteries.	O
Osseous	O
structures:	O
No	O
lytic	O
or	O
sclerotic	O
lesions	O
suspicious	O
for	O
malignancy	O
is	O
present.	O
IMPRESSION:	O
1.	O
No	O
evidence	O
of	O
pulmonary	O
embolism.	O
2.	O
5	O
mm	O
nodule	O
in	O
the	O
left	O
lower	O
lobe.	O
Consider	O
follow	O
up	O
in	O
___	O
year	O
if	O
no	O
prior	O
studies	O
exist	O
for	O
comparison.	O
3.	O
Pulmonary	O
artery	O
hypertension	O
4.	O
Emphysema.	O
Brief	O
Hospital	O
Course:	O
ASSESSMENT	O
AND	O
PLAN:	O
___	O
year	O
old	O
female	O
with	O
PMHx	O
of	O
CAD	O
s/p	O
CABG	O
___,	O
gout,	O
EPO	O
resistant	O
anemia,	O
ESRD	O
on	O
___	O
HD	O
who	O
presents	O
after	O
a	O
syncopal	O
episode	O
at	O
HD	O
___.	O
#	O
Syncope:	O
Pt	O
with	O
witnessed	O
syncopal	O
episode	O
in	O
post	O
HD	O
setting	O
without	O
associated	O
trauma.	O
Seems	O
most	O
likely	O
to	O
be	O
orthostatic	O
given	O
setting	O
of	O
post-HD	O
and	O
+orthostatics	O
here.	O
On	O
dihydropyridine	O
CCB	O
which	O
increases	O
risk.	O
Resolved	O
orthostatics	O
with	O
250mL	O
bolus.	O
History	O
not	O
consistent	O
with	O
seizure	B-Seizures
or	O
CVA.	O
Negative	O
for	O
acute	O
coronary	O
syndrome.	O
CTA	O
negative	O
for	O
PE.	O
No	O
arrythmia	O
on	O
EKG	O
or	O
telemetry.	O
This	O
was	O
likely	O
provoked	O
by	O
the	O
patient	O
being	O
slightly	O
hypovolemic	O
after	O
HD,	O
partially	O
from	O
minimal	O
PO	O
intake	O
in	O
the	O
12	O
hours	O
prior	O
to	O
HD.	O
Her	O
estimated	O
dry	O
weight	B-Weight_loss
from	O
last	O
admission	O
was	O
68.5	O
kg.	O
She	O
weighed	B-Weight_loss
64.5	O
kg	O
at	O
discharge.	O
Patient	O
thinks	O
her	O
dry	O
wt	O
around	O
140lbs.	O
Consideration	O
may	O
be	O
given	O
to	O
an	O
alternative	O
antihypertensive	O
with	O
mortality	O
benefit	O
in	O
CAD	O
(such	O
as	O
a	O
beta-blocker).	O
#.	O
Lung	O
nodule:	O
5	O
mm	O
nodule	O
incidentally	O
identified	O
in	O
the	O
left	O
lower	O
lobe.	O
-	O
will	O
need	O
follow	O
up	O
CT	O
in	O
one	O
year	O
#.	O
ESRD:	O
Pt	O
with	O
left	O
AV	O
fistula	O
on	O
___	O
HD.	O
Outpatient	O
dialysis	O
unit:The	O
___.	O
Outpatient	O
___	O
___.	O
Last	O
full	O
HD	O
was	O
today.	O
She	O
was	O
continued	O
on	O
calcium	O
acetate	O
and	O
nephrocaps	O
with	O
a	O
2	O
gram	O
potassium	O
and	O
sodium	O
diet.	O
Next	O
HD	O
will	O
be	O
___.	O
Her	O
estimated	O
dry	O
weight	O
from	O
last	O
admission	O
was	O
68.5	O
kg.	O
She	O
weighed	O
64.5	O
kg	O
at	O
discharge.	O
Patient	O
thinks	O
her	O
dry	O
wt	O
around	O
140lbs.	O
#.	O
CAD:	O
Pt	O
is	O
s/p	O
CABG	O
(SVG	O
to	O
LAD	O
and	O
SVG	O
to	O
ramus),	O
last	O
cath	O
___	O
with	O
60%	O
ulcerated	O
left	O
main,	O
30%	O
___	O
and	O
30%	O
mid	O
LAD,	O
30%	O
mid	O
LCx,	O
60%	O
OM1,	O
30%	O
mid	O
RCA	O
(right	O
dominant).	O
Not	O
currently	O
on	O
beta-blocker	O
or	O
___.	O
Home	O
package:	O
ASA	O
81',	O
atorva	O
40',	O
nifedipine	O
XL	O
30mg	O
q	O
___.	O
Had	O
3	O
sets	O
of	O
enzymes	O
with	O
stable	O
elevated	O
troponins	O
in	O
setting	O
of	O
ESRD	O
but	O
no	O
EKGs	O
changes	O
and	O
flat	O
CKMBs.	O
We	O
continued	O
aspirin	O
81mg	O
daily,	O
atorvastatin	O
40mg	O
daily,	O
and	O
nifedipine.	O
___	O
consider	O
beta-blocker	O
for	O
secondary	O
MI	O
prevention	O
as	O
an	O
outpatient.	O
#.	O
Anemia:	O
Likely	O
from	O
ESRD.	O
Thought	O
to	O
be	O
EPO	O
resistant	O
given	O
high	O
doses	O
during	O
HD	O
with	O
relative	O
anemia.	O
Pt	O
with	O
H/H	O
of	O
10.5/34.9	O
which	O
is	O
up	O
from	O
H/H	O
of	O
7.9/	O
26.9	O
on	O
prior	O
discharge.	O
No	O
transfusion	O
required	O
this	O
admission.	O
#.	O
Bone/Mineral:	O
Ca	O
___.	O
Nephrology	O
holding	O
calcitriol.	O
Phos	O
slightly	O
high.	O
Home	O
calcium	O
acetate	O
was	O
continued.	O
The	O
patient	O
may	O
benefit	O
from	O
reduced	O
calcitriol	O
or	O
a	O
non-calcium	O
phosphorus	O
binder	O
if	O
persistently	O
elevated.	O
#.	O
Access:	O
LUE	O
AVF	O
#.	O
Code	O
status	O
this	O
admission:	O
DNR/DNI,	O
consistent	O
with	O
prior	O
TRANSITIONAL	O
ISSUES:	O
-f/u	O
CT	O
in	O
12	O
months	O
for	O
5mm	O
pulmonary	O
nodule	O
in	O
left	O
lower	O
lobe	O
(patient	O
counseled	O
about	O
this)	O
-consider	O
less	O
aggressive	O
volume	O
removal	O
during	O
HD	O
as	O
she	O
was	O
under	B-Weight_loss
her	O
nominal	O
dry	O
weight	B-Weight_loss
at	O
BID	O
-consider	O
changing	O
antihypertensive	O
to	O
reduce	O
risk	O
of	O
orthostasis	O
and	O
for	O
better	O
CAD	O
secondary	O
prevention	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
40	O
mg	O
PO	O
DAILY	O
4.	O
Calcium	O
Acetate	O
1334	O
mg	O
PO	O
HS	O
5.	O
Nephrocaps	O
1	O
CAP	O
PO	O
DAILY	O
6.	O
NIFEdipine	O
CR	O
30	O
mg	O
PO	O
QPM	O
7.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
PRN	O
chest	O
pain	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Atorvastatin	O
40	O
mg	O
PO	O
DAILY	O
3.	O
Calcium	O
Acetate	O
1334	O
mg	O
PO	O
HS	O
4.	O
Nephrocaps	O
1	O
CAP	O
PO	O
DAILY	O
5.	O
NIFEdipine	O
CR	O
30	O
mg	O
PO	O
QPM	O
6.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
PRN	O
chest	O
pain	O
7.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
#End	O
stage	O
renal	O
disease	O
#Orthostatic	O
hypotension	O
#Anemia	O
#Coronary	O
artery	O
disease	O
#Pulmonary	O
nodule,	O
left	O
lower	O
lobe	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Ms.	O
___,	O
you	O
were	O
admitted	O
to	O
the	O
hospital	O
after	O
having	O
an	O
episode	O
of	O
fainting	O
after	O
dialysis.	O
We	O
found	O
that	O
you	O
did	O
not	O
have	O
evidence	O
for	O
a	O
heart	O
attack	O
and	O
that	O
you	O
did	O
not	O
have	O
clots	O
in	O
your	O
lungs,	O
both	O
of	O
which	O
can	O
sometimes	O
cause	O
your	O
blood	O
pressure	O
to	O
drop.	O
Your	O
blood	O
pressure	O
was	O
a	O
little	O
low	O
when	O
you	O
were	O
here,	O
and	O
dropped	O
when	O
you	O
stood	O
up.	O
We	O
think	O
this	O
is	O
because	O
you	O
were	O
slightly	O
dehydrated.	O
We	O
gave	O
you	O
a	O
small	O
amount	O
of	O
fluid	O
and	O
your	O
blood	O
pressure	O
improved.	O
Your	O
blood	O
pressure	O
medication	O
may	O
cause	O
this	O
as	O
a	O
side-effect,	O
but	O
we	O
still	O
feel	O
that	O
it	O
is	O
necessary.	O
Followup	O
Instructions:	O
___	O

